Skip to main content
Caplight Logo









MODAG

MODAG

Private
WendelsheimHealthcare & Life Scienceshttps://www.modag.net/

Last Round

Grant

Dec 12, 2023

Total Funding Raised

$17.3M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

MODAG is a biotechnology company that focuses on the research and development of therapeutics and diagnostics for neurodegenerative diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Medical Imaging

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

synucleinopathiesdisease-modifying therapyalpha-synuclein targetsmall molecule therapyMultiple System AtrophyMSAParkinson's diseasePDprotein aggregation inhibitoroligomer modulatorneurodegenerative diseaseclinical-stage biotechPET tracerspharma licensingmolecular imagingblood-brain barrier penetrantAlzheimer's disease

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MODAG Comparables

Compare MODAG with similar companies based on industry and business-model similarity.

MODAG comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Kainos Medicine Inc.
84%
Neuropore Therapies, Inc.
83%
Enterin
83%

MODAG Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantDec 12, 2023
GrantAug 5, 2020
Series AJun 27, 2019

Key People

Founding team and executive leadership

Andreas Kranzusch

CFO

Executive Team

MODAG Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 24, 2026

    Monthly visitors grew 58% MoM, from 685 to 1.1K.

  • May 18, 2026

    Monthly visitors increased 31% MoM, reaching 1.1K.

MODAG Filings

Explore SEC and related filing metadata, where available.

MODAG filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about MODAG's valuation, stock price, and market status.

Is MODAG a public or private company?

MODAG is a private company.

What is the current stock price of MODAG?

MODAG is a private company with no public stock price. No recent secondary market data is available.

How much is MODAG worth (valuation)?

Valuation information for MODAG is not publicly available.

Can I buy MODAG stock?

MODAG shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was MODAG's last funding round?

MODAG's most recent funding round was Grant on December 12, 2023.

Who are the main investors in MODAG?

Key investors in MODAG include Massa Investment AG.

Will MODAG IPO soon?

No public IPO plans have been announced for MODAG.

How can I track MODAG secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor MODAG's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersWendelsheim
Employee Range11
Year Founded2013
Last FundingDec 12, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?